BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31550657)

  • 1. The failure of a DNA prime/protein boost regime and CTLA-4 mediated targeting to improve the potency of a DNA vaccine encoding Fasciola hepatica phosphoglycerate kinase in sheep.
    Wesołowska A; Basałaj K; Zawistowska-Deniziak A; Januszkiewicz K; Kozak Ljunggren M; Jedlina L; Wędrychowicz H
    Vet Immunol Immunopathol; 2019 Nov; 217():109941. PubMed ID: 31550657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses in rats and sheep induced by a DNA vaccine containing the phosphoglycerate kinase gene of Fasciola hepatica and liver fluke infection.
    Wesołowska A; Zawistowska-Deniziak A; Norbury LJ; Wilkowski P; Januszkiewicz K; Pyziel AM; Zygner W; Wędrychowicz H
    Acta Parasitol; 2016 Mar; 61(2):212-20. PubMed ID: 27078643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte responses of rats vaccinated with cDNA encoding a phosphoglycerate kinase of Fasciola hepatica (FhPGK) and F. hepatica infection.
    Wesołowska A; Zawistowska-Deniziak A; Norbury LJ; Wilkowski P; Pyziel AM; Zygner W; Wędrychowicz H
    Parasitol Int; 2018 Feb; 67(1):85-92. PubMed ID: 28385589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime/protein boost strategy.
    Kennedy NJ; Spithill TW; Tennent J; Wood PR; Piedrafita D
    Vaccine; 2006 Feb; 24(7):970-9. PubMed ID: 16242220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep.
    Maggioli G; Acosta D; Silveira F; Rossi S; Giacaman S; Basika T; Gayo V; Rosadilla D; Roche L; Tort J; Carmona C
    Vaccine; 2011 Nov; 29(48):9057-63. PubMed ID: 21939713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke.
    Wedrychowicz H; Kesik M; Kaliniak M; Kozak-Cieszczyk M; Jedlina-Panasiuk L; Jaros S; Plucienniczak A
    Vet Parasitol; 2007 Jun; 147(1-2):77-88. PubMed ID: 17481823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective efficacy of liver fluke DNA vaccines: A systematic review and meta-analysis: Guiding novel vaccine development.
    Jayaraj R; Kumarasamy C; Norbury L; Piedrafita D; Smooker P
    Vet Parasitol; 2019 Mar; 267():90-98. PubMed ID: 30878093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a multivalent vaccine against Fasciola hepatica infection in sheep.
    Zafra R; Buffoni L; Pérez-Caballero R; Molina-Hernández V; Ruiz-Campillo MT; Pérez J; Martínez-Moreno Á; Martínez Moreno FJ
    Vet Res; 2021 Jan; 52(1):13. PubMed ID: 33509286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray analysis of rat immune responses to liver fluke infection following vaccination with Fasciola hepatica phosphoglycerate kinase.
    Wesołowska A; Jaros S; Norbury LJ; Jaros D; Zygner W; Wędrychowicz H
    Exp Parasitol; 2013 May; 134(1):33-8. PubMed ID: 23376446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological, immunological and parasitological study of sheep vaccinated with the recombinant protein 14-3-3z and experimentally infected with Fasciola hepatica.
    Pérez-Caballero R; Siles-Lucas M; González-Miguel J; Martínez-Moreno FJ; Escamilla A; Pérez J; Martínez-Moreno A; Buffoni L
    Vet Immunol Immunopathol; 2018 Aug; 202():115-121. PubMed ID: 30078585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel ex vivo immunoproteomic approach characterising Fasciola hepatica tegumental antigens identified using immune antibody from resistant sheep.
    Cameron TC; Cooke I; Faou P; Toet H; Piedrafita D; Young N; Rathinasamy V; Beddoe T; Anderson G; Dempster R; Spithill TW
    Int J Parasitol; 2017 Aug; 47(9):555-567. PubMed ID: 28455238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking Fasciola hepatica's energy metabolism - a pilot study of vaccine potential of a novel gene - phosphoglycerate kinase.
    Jaros S; Jaros D; Wesolowska A; Zygner W; Wedrychowicz H
    Vet Parasitol; 2010 Sep; 172(3-4):229-37. PubMed ID: 20538413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of Quil A adjuvant on the course of experimental Fasciola hepatica infection in sheep.
    Haçariz O; Sayers G; McCullough M; Garrett M; O'Donovan J; Mulcahy G
    Vaccine; 2009 Jan; 27(1):45-50. PubMed ID: 18977261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver fluke vaccines in ruminants: strategies, progress and future opportunities.
    Toet H; Piedrafita DM; Spithill TW
    Int J Parasitol; 2014 Oct; 44(12):915-27. PubMed ID: 25200351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione S-transferase. Novel vaccine against Fasciola hepatica infection in sheep.
    Sexton JL; Milner AR; Panaccio M; Waddington J; Wijffels G; Chandler D; Thompson C; Wilson L; Spithill TW; Mitchell GF
    J Immunol; 1990 Dec; 145(11):3905-10. PubMed ID: 1978849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparative efficacy of CTLA-4 and L-selectin targeted DNA vaccines in mice and sheep.
    Drew DR; Boyle JS; Lew AM; Lightowlers MW; Chaplin PJ; Strugnell RA
    Vaccine; 2001 Aug; 19(31):4417-28. PubMed ID: 11483267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory molecules of Fasciola hepatica: candidates for both vaccine and immunotherapeutic development.
    Dalton JP; Robinson MW; Mulcahy G; O'Neill SM; Donnelly S
    Vet Parasitol; 2013 Aug; 195(3-4):272-85. PubMed ID: 23623183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phage display-based vaccine with cathepsin L and excretory-secretory products mimotopes of Fasciola hepatica induces protective cellular and humoral immune responses in sheep.
    Villa-Mancera A; Olivares-Pérez J; Olmedo-Juárez A; Reynoso-Palomar A
    Vet Parasitol; 2021 Jan; 289():109340. PubMed ID: 33373968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin L proteinases as vaccines against infection with Fasciola hepatica (liver fluke) in ruminants.
    Mulcahy G; Dalton JP
    Res Vet Sci; 2001 Feb; 70(1):83-6. PubMed ID: 11170858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An attempt to vaccinate sheep against Fasciola hepatica using a juvenile fluke antigen sheep antibody complex.
    Sandeman RM; Howell MJ; Campbell NJ
    Res Vet Sci; 1980 Sep; 29(2):255-9. PubMed ID: 6110229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.